SCHEMBL22894463

SCHEMBL22894463

Cc1nc(-c2ccc(NC(=O)Cc3ccccc3Cl)cc2SN)sc1C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CLK2 P49760 1/20 0.46
▸ PRKX P51817 1/20 0.46
▸ CAMK2D Q13557 1/20 0.46
▸ PKN2 Q16513 1/20 0.46
▸ CLK4 Q9HAZ1 1/20 0.46
▸ STK17A Q9UEE5 1/20 0.46
▸ KCNJ5 P48544 7/20 0.46
▸ KCNJ3 P48549 7/20 0.46
▸ ROCK2 O75116 3/20 0.45
▸ ROCK1 Q13464 2/20 0.45
▸ KCNJ6 P48051 3/20 0.45
▸ ALDH1A1 P00352 1/20 0.45
▸ LMNA P02545 1/20 0.45
▸ POLB P06746 1/20 0.45
▸ THRB P10828 1/20 0.45
▸ NPC1 O15118 2/20 0.44
▸ RAB9A P51151 2/20 0.44
▸ ANO1 Q5XXA6 2/20 0.42
▸ P2RX4 Q99571 2/20 0.41
▸ CSNK1D P48730 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19552663 0.84 P2RX4 (0.56) KCNJ5KCNJ3KCNJ6ALDH1A1LMNA
SCHEMBL29716816 0.84 P2RX4 (0.56) KCNJ5KCNJ3KCNJ6ALDH1A1LMNA
SCHEMBL22894360 0.82 ROCK2 (0.48) CLK2PRKXCAMK2DPKN2CLK4
SCHEMBL19576971 0.78 KCNJ5 (0.48) CLK2PRKXCAMK2DPKN2CLK4
SCHEMBL19576513 0.74 P2RX4 (0.44) KCNJ5KCNJ3KCNJ6ALDH1A1LMNA
SCHEMBL19576891 0.73 KCNJ5 (0.52) CLK2PRKXCAMK2DPKN2CLK4
SCHEMBL23620189 0.73 NR2E1 (0.49) KCNJ5KCNJ3KCNJ6ALDH1A1LMNA
SCHEMBL22353143 0.72 KCNJ5 (0.44) CLK2PRKXCAMK2DPKN2CLK4
SCHEMBL22353174 0.72 KCNJ5 (0.55) CLK2PRKXCAMK2DPKN2CLK4
SCHEMBL19576904 0.72 KCNJ5 (0.53) CLK2PRKXCAMK2DPKN2CLK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3763704-A1 AROMATIC SULFONAMIDE DERIVATIVES Bayer Pharma Aktiengesellschaft (DE) 2021-01-13 — — EP disclosed
Send feedback